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A B S T R A C T
Introduction and objectives: High-interval intensity training (HIT) has been suggested to improve peak
VO2 in cardiac rehabilitation programs. However, the optimal HIT protocol is unknown. The objective of
this study was to identify the most effective doses of HIT to optimize peak VO2 in coronary artery disease
(CAD) and heart failure (HF) patients.
Methods: A search was conducted in 6 databases (MEDLINE, Web of Science, LILACS, CINAHL, Academic
Search Complete, and SportDiscus). Studies using a HIT protocol in CAD or HF patients and measuring
peak VO2 were included. The PEDro Scale and Cochrane Collaboration tools were used.
Results: Analyses reported signiﬁcant improvements in peak VO2 after HIT in both diseases (P =
.000001), with a higher increase in HF patients (P = .03). Nevertheless, in HF patients, there were no
improvements when the intensity recovery was  40% of peak VO2 (P = .19) and the frequency of training
was  2 d/wk (P = .07). There were signiﬁcant differences regarding duration in CAD patients, with
greater improvements in peak VO2when the duration was < 12 weeks (P = .05). In HF, programs lasting <
12 weeks did not signiﬁcantly improve peak VO2 (P = .1).
Conclusions: The HIT is an effective method for improving peak VO2 in HF and CAD, with a signiﬁcantly
greater increase in HF patients. The recovery intervals should be active and be between 40% and 60% of
peak VO2 in HF patients. Training frequency should be  2 d/wk for CAD patients and  3 d/wk for HF
patients.
C 2018 Sociedad Espan˜ola de Cardiologı´a. Published by Elsevier Espan˜a, S.L.U. All rights reserved.
Dosis de ejercicio interva´lico de alta intensidad en la rehabilitacio´n cardiaca de la
insuficiencia cardiaca y la enfermedad arterial coronaria: revisio´n sistema´tica
y metana´lisis
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R E S U M E N
Introduccio´n y objetivos: Se ha propuesto el ejercicio interva´lico de alta intensidad (EIAI) en programas de
rehabilitacio´n cardiaca para mejorar el VO2ma´x. Sin embargo, no se conoce cua´l es el mejor protocolo EIAI.
El objetivo es encontrar la mejor dosis de EIAI para optimizar el VO2ma´x de pacientes con enfermedad
arterial coronaria (EAC) e insuﬁciencia cardiaca (IC).
Me´todo: Se llevo´ a cabo una bu´squeda en 6 bases de datos (MEDLINE, Web of Science, LILACS, CINAHL,
Academic Search Complete y SportDiscus). Se incluyeron los estudios que usaban el protocolo EIAI y
midieron el VO2ma´x de pacientes con EAC e IC. Se utilizo´ la escala PEDro y las herramientas de la
Colaboracio´n Cochrane.
Resultados: El ana´lisis mostro´ mejoras signiﬁcativas en el VO2ma´x tras el EIAI en ambas enfermedades
(p = 0,000001), con mayor incremento en los pacientes con IC (p = 0,03). Sin embargo, en estos no hubo
mejora si la intensidad de recuperacio´n era  40% del VO2ma´x (p = 0,19) o la frecuencia de entrenamiento
era  2 dı´as/semana (p = 0,07). Hubo diferencias signiﬁcativas segu´n la duracio´n entre los pacientes con
EAC, que mostraron resultados superiores cuando era < 12 semanas (p = 0,05). Los pacientes con IC no
mostraron mejoras signiﬁcativas en el VO2ma´x cuando la duracio´n era < 12 semanas (p = 0,1).* Corresponding author: Facultad de Educacio´n, Universidad de Almerı´a, Carretera Sacramento s/n, 04120 La Can˜ada, Almerı´a, Spain.
E-mail address: carrasco@ual.es (M. Carrasco Poyatos).
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mayor diferencia signiﬁcativa en los pacientes con IC. Los intervalos de recuperacio´n de los pacientes
con IC deben ser activos y estar en un 40-60% del VO2ma´x. La frecuencia de entrenamiento deberı´a ser
 2 dı´as/semana en la EAC y  3 dı´as/semana en la IC.
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CAD: coronary artery disease
HF: heart failure
HIT: high-intensity interval training
Peak VO2: peak oxygen uptakeINTRODUCTION
Coronary artery disease (CAD) is one of the most common
causes of death worldwide, affecting 17.5 million people each
year.1 Ischemic disease and chronic heart failure (HF) are lethal,
causing 8.76 million deaths worldwide,2 resulting in higher health
care system spending.3 These CAD reduce either exercise tolerance
or peak oxygen uptake (peak VO2), culminating in heart,
respiratory, and endothelial dysfunction.4 In addition, HF is the
ﬁnal condition of all cardiovascular diseases, as it affects both
cardiac function and cardiovascular circulation.5 For this reason,
they are deﬁned as an incapacity syndrome, which creates
morbidity and whose symptoms are linked to fatigue, dyspnea,
and exercise intolerance.4
Currently, it has been widely proven that one of the beneﬁts of
aerobic exercise is an increase in peak VO2,
6–9 which is one of the
most important survival indicators for people with CAD5,10–13 and
HF.5 Continuous aerobic training has been studied for cardiac
rehabilitation programs. It consists of performing exercise for a
long period of time under moderate intensity and nonvariable
aerobic activity (60%-80% of peak VO2
5,9,11,12,14). However, at
present, high-intensity interval training (HIT) protocols are
generating better results in peak VO2 in less time.
9,13–16 They
consist of intermittent short high-intensity work periods (85%-
100% of peak VO2) and relative rest periods.
10,15 A typical HIT
session consists of a 10-minute warm-up at 50% to 70% of peak VO2
followed by a set of four 3- to 4-minute bouts5,10–13,15–23 (HIT
protocol with long work interval) or a set of ten 30- to 60-second
bouts6–9,24 (HIY protocol with short work interval) at 85% to 95% of
peak VO2 interspersed by active pauses at 50% to 70% of peak VO2.
It terminates with a cool-down period at 50% to 70% of peak VO2
25
(Figure 1). However, although HIT is known to produce the greatest
effects on peak VO2 in CAD and HF patients,
5,13,15,16,21 there have
been many differences in the exercise protocols proposed in this
topic affecting the frequency (2-5 d/wk),8,11,14,24 volume (30-
60 min/sessions),15,24,26 intensity of recovery (0%-70% peak
VO2),
6,9,17,21 number of sessions (> 100 sessions),13 duration of
training (4-50 weeks),8,13,16,18 and even in the characteristics of the
patients.11,17,21 Recognizing the inﬂuence of these variables
regarding peak VO2 could help to optimize cardiac rehabilitation
programs for HF and CAD patients.
Moreover, other studies have focused on identifying which kind
of HIT intervention is more effective for improving the functional
capacity of HF and CAD patients, as the rehabilitation process and
the disabilities produced by the 2 diseases differ.10,27 However,
which HIT protocol training is better for one disease or the other, or
the best dosage of this type of exercise to improve the cardiac
rehabilitation program of each disease is currently not known.Please cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp Therefore, the aim of the present study was to conduct a meta-
analysis to a) identify the best doses of HIT to optimize HIT training
for HF and CAD patients, and b) determine how the HIT protocol
affects HF and CAD patients in terms of their peak VO2.
METHODS
Study Design
The systematic review and meta-analysis were undertaken in
accordance with the PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) statement.28 The search
was carried out by 2 of the authors (I. Ballesta Garcı´a and J.A. Rubio
Arias), and all the authors reached an agreement regarding
methods, article inclusion, and statistical analysis. The articles
were organized in order to delete duplicates. Full-text articles were
retrieved and evaluated based on the proposed selection criteria.
Variables related to the training method such as frequency, total
duration of the session, exercise duration, and recovery intervals,
number of total sessions, percentage of intensity of each interval,
as well as the age, body mass index, sex and number of patients in
each study were extracted to an excel workbook.
Search Strategy
Electronic database searches were performed using MEDLINE,
Web of Science, LILACS, CINAHL, Academic Search Complete and
SportDiscus. The search terms chosen were: (‘‘Heart disease’’ OR
‘‘Heart Failure’’ OR ‘‘Coronary Artery Disease’’ OR CAD) AND
(‘‘High-intensity’’ OR ‘‘High intensity’’ OR HIT OR ‘‘Interval
training’’). The search results and ﬁnal study selection are shown
in Figure 2.
Inclusion Criteria
Inclusion criteria were determined by the authors. We included
randomized controlled trials, written in English or Spanish,
published from January 2004 to March 2017, using a HIT protocol
in patients with CAD or HF, measuring peak VO2. We excluded
studies based on aquatic HIT programs, combining HIT with
strength training, home-based HIT, not considering CAD and HF
results of peak VO2 independently, using people with transplants,
grafts or with valve disease, and testing with food supplements,
nutritional or pharmacological aids.
Statistical Analysis
The meta-analysis and statistical analysis were developed using
Review Manager software (RevMan 5.2; Cochrane Collaboration,
Oxford, United Kingdom)29 and Comprehensive Meta-analysis
software (Version 2; Biostat, Englewood, New Jersey, United
States). A random effects meta-analysis was conducted to
determine which disease most beneﬁted from HIT and if there
were differences between HIT protocols for each condition. The
work-rest ratio, the work interval duration and intensity, and theterval Training Dosage for Heart Failure and Coronary Artery Disease
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Figure 1. Schematic illustration for HIT_S and HIT_L. HIT, high-intensity interval training groups; HIT_L, protocol of HIT with long work intervals; HIT_S, protocol of
HIT with short work intervals.
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Figure 2. Systematic review and meta-analysis ﬂow diagram. WOS, Web of Science.
I. Ballesta Garcı´a et al. / Rev Esp Cardiol. 2018;xx(x):xxx–xxx 3
G Model
REC-3674; No. of Pages 11
Please cite this article in press as: Ballesta Garcı´a I, et al. High-intensity Interval Training Dosage for Heart Failure and Coronary Artery Disease
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp Cardiol. 2018. https://doi.org/10.1016/j.rec.2018.02.015
Table 1
General Characteristics of the Studies Included in the Meta-analysis
Research studies Study location, country Disease n_HIT Men, % Age, y BMI, cm/kg2
Benda et al.24 Nijmegen, Netherlands HF 10 100 63.0  8 28.1  7.5
Cardozo et al.11 Rio de Janerio, Brasil CAD 23 63 56.0  12 27.5  5.9
Chrysohoou et al.6 Rio de Janerio, Brasil HF 33 88 63.0  9 28.8  4.2
Conraads et al.18 Athens, Greece CAD 100 85 57.0  8.8 28  4.4
Currie et al.9 Hamilton, Canada CAD 11 91 67.2  6 27.9  4.9
Dimopoulos et al.27 Athens, Greece HF 10 90 59.2  12.2 26.5  4.1
Freyssin et al.8 Reunion island, France HF 13 50 54.0  9 24.8  4
Fu et al.16 Keelung, Taiwan HF 14 61 67.5  1.8
Huang et al.19 Taoyuan, Taiwan HF 33 78 60.0  3
Isaksen et al.17 Stavanger, Norway HF 24 88 65.0  9 27.8  4
Kim et al.15 Seoul, Korea CAD 14 86 57.0  11.5 24.2  2.9
Koufaki et al.30 Staffordshire, England HF 16 87 59.8  7.4 28.9  4.7
Madssen et al.13 Trondheim, Norway CAD 24 75 64.4 [47-78] 28  3.9
Moholdt et al.31 Trondheim, Norway CAD 28 86 60.2  6.9 26  6.2
Moholdt et al.21 Trondheim, Norway CAD 11 83 57.7  9.3 26.6  3
Roditis et al.7 Athens, Greece HF 11 90 63.0  2 25.9  2.8
Rognmo et al.32 Trondheim, Norway CAD 8 75 62.9  11.2 26.7  4.1
Smart et al.33 Athens, Greece HF 10 100 59.1  11 28.9  6.1
Warburton et al.34 Vancouver, Canada CAD 7 100 55.0  7
BMI, body mass index; CAD, coronary artery disease; HF, heart failure; n_HIT number of participants in high-intensity interval training groups.
Data are presented as the mean, mean  standard deviation, range or No.
SE (MD)0
2
4
6
8
10
Subgroups
CAD HF
—10 —5 0 5 10
MD
Figure 3. Funnel plot of comparison: CAD vs HF. CAD, coronary artery disease;
HF, heart failure; MD, mean difference; SE, standard error.
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changes in each variable.
Due to the heterogeneity of the protocol (Table 1), mean
differences were used, dividing the mean values between
2 different groups. The differences in means were grouped using
the random effects model. Heterogeneity between studies was
analyzed using I2 statistics. The dichotomous and continuous
variables of the studies were compared with extracted potential
peak VO2 moderator factors. The medians of continuous variables
were used to group the studies. Afterwards, HIT differences
between pre- and post-values were expressed and analyzed as
potential moderator variable changes. The publication bias for the
different conditions analyzed (pre-vs-post) was assessed by
examining the asymmetry of a funnel plot using Egger’s test,
and P  .05 was considered to be statistically signiﬁcant. We
assessed the methodological quality of the studies by using the
PEDro Scale. The risk of bias was assessed using the modiﬁed
Cochrane Collaboration tools. Bias was assessed as a judgment
(high, low, or unclear) for individual elements from 5 domains:
selection, performance, attrition, reporting and any other bias
(criteria inclusion of patients in the studies and the country in
which the study was conducted).
RESULTS
According to our inclusion criteria, 19 studies were included in
this meta-analysis, 10 in HF and 9 in CAD. The Egger test provided
statistical evidence of funnel plot symmetry (Figure 3), suggesting
the absence of a signiﬁcant publication bias.
Risk-of-bias assessment is shown in Figure 4. It was high in
almost all studies due to lack of blinding of participants and
personnel. However, this issue could not be omitted due to the
peculiarity of the intervention (exercise vs no exercise) and should
be considered in perspective.
The main characteristics of the studies and of training
interventions are described in Table 1 and Table 2, respectively.Please cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp The meta-analyzed effects of HIT found in both diseases were
beneﬁcial (P < .000001) for peak VO2 (3.98; 95%CI, 2.94-5.02 mL/
kg/min for CAD patients and 2.55; 95%CI, 1.73-3.36 mL/kg/min for
HF patients) (Figure 5). However, there were signiﬁcant differences
in peak VO2 between the 2 diseases in favor of HF patients (P = .03)
(Figure 5).
Following the moderating variables, the results showed
statistical improvements in peak VO2 in each subgroup analyzed
for both diseases (P < .05) (Table 3 and Table 4). There were no
statistically signiﬁcant differences between subgroups according
to population characteristics in CAD or HF (Table 3 and Table 4).
Regarding exercise characteristics, there were statistically
signiﬁcant improvements in peak VO2 in each CAD patient
subgroup analyzed (P < .05). Nevertheless, in HF patients, there
were no improvements in peak VO2 when the intensity of recovery
was  40% peak VO2 (P = .19), when the type of recovery was
passive (P = .09), and in the  2 d/wk protocols (P = .07)9,24
(Table 5).terval Training Dosage for Heart Failure and Coronary Artery Disease
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Figure 4. Assessment of risk of bias in included randomized controlled trials.
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differences in CAD patients, who showed higher peak VO2
improvements when the program was performed for < 12 weeks
(P = .05) (Table 6). By contrast, there were no signiﬁcant differences
in HF patients when comparing a program  12 weeks and a
program  12 weeks (P = .96). However, a program lasting 
12 weeks did not produce signiﬁcant improvements in peak VO2 in
HF patients (P = .1; I2 = 0) (Table 5).
Likewise, there were no signiﬁcant differences between HIT
protocols with short exercise intervals and protocols with long
exercise intervals in either of the 2 diseases (P = .87), although both
of them showed signiﬁcant improvements in peak VO2 (P = <
.000001). In contrast, there were signiﬁcant differences in peak
VO2 between the 2 diseases in favor of HF patients (P = .03)
(Figure 5).Table 2
Characteristics of Aerobic Training Interventions in the Studies Included in the M
Studies Disease Type Frequency,
wks
Session
duration,
min
Interval
work, min
Int
rec
Benda et al.24 HF HIT_S 2 30 1 2 
Cardozo et al.11 CAD HIT_L 3 28 4 3 
Chrysohoou et al.6 HF HIT_S 3 45 0.5 0.5
Conraads et al.18 CAD HIT_L 3 28 4 3 
Currie et al.9 CAD HIT_S 2 20 1 1 
Dimopoulos et al.27 HF HIT_S 3 36 0.5 0.5
Freyssin et al.8 HF HIT_S 5 69 0.5 1 
Fu et al.16 HF HIT_L 3 30 3 3 
Huang et al.19 HF HIT_L 3 42 3 3 
Isaksen et al.17 HF HIT_L 3 28 4 3 
Kim et al.15 CAD HIT_L 3 28 4 3 
Koufaki et al.30 HF HIT_S 3 — 0.5 1 
Madssen et al.13 CAD HIT_L 3 28 4 3 
Moholdt et al.31 CAD HIT_L 5 28 4 3 
Moholdt et al.21 CAD HIT_L 3 28 4 3 
Roditis et al.7 HF HIT_S 3 40 0.5 0.5
Rognmo et al.32 CAD HIT_L 3 28 4 3 
Smart et al.33 HF HIT_S 3 60 1 1 
Warburton et al.34 CAD HIT_S 3 — 2 3 
CAD, coronary artery disease; HF, heart failure; HIT, high-intensity interval training grou
work interval; peak VO2, peak oxygen uptake; R: work/recovery ratio.
a Percentage of peak VO2 of the interval work.
b Percentage of increase of VO2 peak posttraining.
Please cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp DISCUSSION
This meta-analysis determined how different HIT protocols
modify the peak VO2 of HF and CAD patients, describing the most
effective doses of HIT to optimize their training. The main ﬁnding
was that HIT was more effective for improving the peak VO2 of
patients with HF than that of those with CAD. However, the
maximum beneﬁts in peak VO2were obtained between weeks 6 and
12 for both diseases. In addition, HF patients did not
obtain signiﬁcant peak VO2 improvements when the HIT protocol
was > 12 weeks. This result may be due to the fact that
only 2 studies30,33 followed a protocol > 12 weeks while
8 studies6–8,16,17,19,24,27 followed protocols of  12 weeks. In fact,
no signiﬁcant differences were found between the 2 subgroups
(P = .96). Likewise, CAD patients achieved greater improvements ineta-analysis
erval
overy, min
Duration,
wks
Number
of sessions
Work intensity,
% peak VO2
a
R Increase
VO2 peak, %
b
12 24 90 0.5 6.8
16 48 90 1.33 18.44
 12 36 100 1 31.25
12 36 90-95 1.33 21.7
12 24 80-100 1 23.73
 12 36 100 1 7.79
8 40 80-95 0.5 27.1
12 36 80 1 22.5
12 36 80 1 13.41
12 36 85 1.33 5.74
6 18 85-95 1.33 22.16
24 72 100 0.5 15.68
52 156 85-95 1.33 3.22
4 20 90 1.33 12.17
12 36 85-95 1.33 14.55
 6 18 100 1 8.45
10 30 80-90 1.33 18.86
48 16 70 0.5 20.49
16 48 85-95 0.66 17.28
ps; HIT_L, protocol of HIT with long work interval; HIT_S, protocol of HIT with short
terval Training Dosage for Heart Failure and Coronary Artery Disease
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Figure 5. A: MD between post- and pre-HIT intervention peak VO2 (mL/kg/min) for patients with CAD. B: MD between post- and pre-HIT intervention peak VO2 (mL/
kg/min) for patients with HF. Squares represent the MD for each trial. The diamond represents the pooled MD across trials. Weight determines how much each
individual study contributes to the pooled estimate.35 Total is the number of participants in HIT groups. 95%CI, conﬁdence interval; CAD, coronary artery disease;
HF, heart failure; HIT, high-intensity interval training groups; MD, mean difference; SD: standard deviation; IV: inverse variance.
Table 3
Subgroup Analyses Assessing Potential Moderating Factors for VO2 Peak Increase in Studies on CAD Disease Included in the Meta-analysis by Population
Characteristics
Research studies Peak VO2
Group HIT groups References MD (95%CI) I2 Pb P-differencec
No. of participantsa
< 14 4 Currie et al.,9 Moholdt et al.,21 Rognmo et al.,32
Warburton et al.34
4.12 (1.75-6.48) 0 .0006 .81
 14 5 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15
Madssen et al.,13 Moholdt et al.31
3.77 (2.14-5.40) 42 < .00001
BMI
25-29.9 kg/m2 6 Cardozo et al.,11 Conraads et al.,18 Currie et al.,9
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.32
4.46 (3.27-6.65) 0 .00001 .48
 24.9 kg/m2 1 Kim et al.15 6.30 (1.34-11.26) 0 < .01
Sex
Men 2 Rognmo et al.,32 Warburton et al.34 3.21 (-0.63-7.04) 0 .1 .71
Men and women 7 Cardozo et al.,11 Conraads et al.,18 Currie et al.,9
Kim et al.,15 Madssen et al.,13 Moholdt et al.,31
Moholdt et al.21
3.97 (2.74-5.20) 16 < .00001
Age, y
> 57 4 Currie et al.,9 Moholdt et al.,31 Moholdt et al.,21
Rognmo et al.32
3.97 (2.02-5.91) 0 < .00001 .86
 57 4 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15
Wanburton et al.34
3.97 (2.02-5.91) 43 < .00001
Methodological quality
> 7 points 5 Cardozo et al.,11 Conraads et al.,18 Currie et al.,9
Madssen et al.,13 Moholdt et al.31
3.72 (2.26-5.19) 36 < .00001 .66
 7 points 4 Kim et al.,15 Madssen et al.,13 Moholdt et al.,21
Wanburton et al.34
4.41 (1.69-7.13) 0 .001
95%CI, 95% conﬁdence interval; BMI, body mass index; HIT, high-intensity interval training groups; I2, heterogeneity; MD, mean difference; peak VO2, peak oxygen uptake.
Certain studies were not included because they did not report the value used for subgroup analysis.
a Number of subjects of the HIT group.
b Test for overall effect.
c Test for subgroup differences.
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Table 4
Subgroup Analyses Assessing Potential Moderating Factors for VO2 Peak Increase in Studies on HF Disease Included in the Meta-analysis by Population
Characteristics
Research studies Peak VO2
Group HIT groups References MD (95%CI) I2 Pb P-differencec
No. of participantsa
< 14 6 Benda et al.,24 Dimopoulos et al.,27 Freyssin et al.,8
Koufaki et al.,30 Roditis et al.,7 Smart et al.33
1.79 (0.40-3.19) 0 .01
.24
 14 4 Chrysohoou et al.,6 Fu et al.,16 Huang et al.,19
Isaksen et al.17
2.87 (1.75-4.00) 72 < .00001
Sex
Men 2 Benda et al.,24 Smart et al.33 1.80 (1.01-4.61) 0
.6
Men and women 8 Chrysohoou,6 Dimopoulos et al.,27 Freyssin et al.,8
Fu et al.,16 Koufaki et al.,30 Huang et al.,19 Isaksen
et al.,17 Roditis et al.7
2.59 (1.68-3.50) 58 < .00001
Age, y
 62 5 Benda et al.,24 Chrysohoou et al.,6 Fu et al.,16 Isaksen
et al.,17 Roditis et al.7
2.66 (0.21-5.11) 67 .03
.73
< 62 5 Dimopoulos et al.,27 Freyssin et al.,8 Huang et al.,19
Smart et al.,33 Koufaki et al.30
2.22 (1.87-2.58) 0 < .00001
BMI
25-29.9 kg/m2 7 Benda et al.,24 Chrysohoou et al.,6 Dimopoulos et al.,27
Isaksen et al.,17 Roditis et al.,7 Smart et al.,33 Koufaki
et al.30
2.04 (0.70-3.38) 14 .003
.36
 24.9 kg/m2 3 Freyssin et al.,8 Fu et al.,16 Huang et al.19 2.85 (1.72-3.99) 79 < .00001
Methodological quality
> 6 points 1 Chrysohoou et al.6 5.00 (2.34-7.66) — .0002
.07
 6 points 9 Benda et al.,24 Dimopoulos et al.,27 Freyssin et al.,8
Fu et al.,16 Huang et al.,19 Isaksen et al.,17 Roditis
et al.,7 Smart et al.,33
Koufaki et al.30
2.41 (1.64-3.17) 40 < .00001
95%CI, 95% conﬁdence interval; BMI, body mass index; HIT, high-intensity interval training groups; I2, heterogeneity; MD, mean difference; peak VO2, peak oxygen uptake.
Certain enrolled studies were not included because the value used for subgroup analysis was not reported in them.
a Number of subjects of the HIT group.
b Test for overall effect.
c Test for subgroup differences.
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the differences being signiﬁcant between the 2 subgroups (P = .05).
Regarding age, there were no statistically signiﬁcant differences
between subgroups ( 57 years and < 57 years, CAD patients [56-
65 years old], and  62 years and < 62 years [54-68 years], HF
patients). This result indicated that age does not inﬂuence
improvements in peak VO2, although some research asserts that
age is a determining factor for the occurrence of HF and CAD due to
diseases associated with age.35,36 According to Amundsen et al.,12
these results suggest that HIT induces changes in cardiac
contractility and increases ﬁlling of the left ventricle. Thus, we
found peak VO2 improvements derived from improvements in left
ventricular ejection fraction, regardless of age.
In relation to the HIT protocol, the studies suggested conducting a
work ratio (work/recovery)  1.33 (0.66-1.33) for patients with CAD,
as it provides the same beneﬁts as ratios > 1.33. Moreover, it would
be better to use work ratios < 1 (0.5-1.33) for patients with HF. These
results support some researchers’ arguments that patients prefer
shorter or less-intense protocols,10 favoring adherence to the long-
term protocol due to greater patient comfort.10,37
Concerning work and recovery periods, there were no statisti-
cally signiﬁcant differences regarding work interval duration (from
30 seconds to 4 minutes) in HF patients. Nevertheless, there were
statistically signiﬁcant differences in recovery intensity, as recover-
ies  40% peak VO2 and passive recovery did not produce
adaptations in peak VO2. The reason may be that an active recovery
at greater intensity allows for the optimization of phosphocreatine
resynthesis, greater lactate oxidation, and optimization of
lactate neoglucogenesis.38 However, although some authors havePlease cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp recommended passive recoveries,10 these were not as effective as
active recoveries.26 For patients with CAD, there were no statistically
signiﬁcant differences in the work and recovery interval duration,
the type of recovery, or active recovery intensity. Thus, patients with
CAD had faster recoveries than HF patients. This ﬁnding could be due
to CAD patients being less affected at the cardiovascular level than
patients with HF, therefore having a faster recovery within the
parameters mentioned.39 Consequently, to improve the cardiac
rehabilitation process, the design of the HIT protocol for HF patients
should include active recoveries  40% peak VO2.
Regarding HIT frequency, there were no statistically signiﬁcant
improvements in the peak VO2 of patients with HF when with
protocols  2 d/wk (P = .07),24 although an improvement was found
in the 3 and 4 d/wk protocols (P < .00001),6,7,16,17,19,27,30,33 and  5 d/
wk protocols (P < .01).8Nevertheless, these results were not found in
patients with CAD, whose peak VO2 improved regardless of
frequency (2-5 d/wk). Therefore, to obtain HIT-related peak VO2
improvements, training frequency should be at least 3 sessions/wk
for patients with HF and at least 2 sessions/wk for patients with CAD.
The differences between diseases may be related to the cardiac
muscle injury of HF patients, requiring a greater training frequency
to obtain similar improvements compared with patients with CAD
who did not have problems with the cardiac muscle.37
Our systematic review and meta-analysis results indicate that
peak VO2 signiﬁcantly increased (P < .00001) after HIT in patients
with CAD regardless of the duration of the program. Nevertheless,
there were signiﬁcant differences between the protocol durations
of > 12 and  12 weeks (P = .05). However, for patients with HF,
even though the programs > 12 weeks did not produce signiﬁcantterval Training Dosage for Heart Failure and Coronary Artery Disease
Cardiol. 2018. https://doi.org/10.1016/j.rec.2018.02.015
Table 5
Subgroup Analyses Assessing Potential Moderating Factors for VO2 Peak Increase in Studies on HF Disease Included in the Meta-analysis by Exercise Characteristics
Peak VO2
Group HIT groups References MD (95%CI) I2 Pa P-differenceb
Number of sessions
 36 sessions 8 Chrysohoou et al.,6 Dimopoulos et al.,27 Freyssin et al.,8 Fu,16
Huang et al.,19 Isaksen et al.,17 Koufaki et al.,30 Smart et al.33
2.69 (1.78-3.60) 56 < .00001
.26
< 36 sessions 2 Benda et al.,24 Roditis et al.7 1.24 (–1.12-3.61) 0 < .00001
Duration
> 12 wks 2 Koufaki et al.,30 Smart et al.33 2.45 (–0.48-5.37) 0 .1
.96
 12 wks 8 Benda et al.,24 Chrysohoou et al.,6 Dimopoulos et al.,27
Freyssin,8 Fu et al.,16 Huang et al.,19 Isaksen et al.,17
Roditis et al.7
2.53 (1.62-3.44) 59 < .00001
HIT frequency
 5 d/wk 1 Freyssin8 2.90 (0.61-5.19) — .01
.77
3 or 4 d/wk 8 Chrysohoou et al.,6 Dimopoulos et al.,27 Fu et al.,16
Huang et al.,19 Isaksen et al.,17 Koufaki et al.,30
Roditis et al.,7 Smart et al.33
2.55 (1.59-3.50) 58 < .00001
 2 d/wk 1 Benda et al.24 1.30 (–2.38-4.98) — .49
Session duration
> 42 min 4 Chrysohoou et al.,6 Freyssin et al.,8 Koufaki et al.,30
Smart et al.33
3.44 (1.95-4.94) 0 < .00001
.19
 42 min 5 Benda et al.,24 Fu et al.,16 Huang et al.,19 Isaksen et al.,17
Roditis et al.7
2.23 (1.23-3.23) 62 < .00001
Interval work
> 45 sec 5 Benda et al.,24 Fu et al.,16 Huang et al.,19 Isaksen et al.,17
Smart et al.33
2.53 (1.50-3.55) 34 .002
1.00
 45 sec 5 Chrysohoou et al.,6 Dimopoulos et al.,27 Freyssin et al.,8
Koufaki et al.,30 Roditis et al.7
2.52 (0.89-4.15) 63 < .00001
Interval recovery
> 1 min 4 Benda et al.,24 Fu et al.,16 Huang,19 Isaksen et al.17 2.46 (1.35-3.58) 73 < .00001
.84
 1 min 6 Chrysohoou et al.,6 Dimopoulos et al.,27 Freyssin et al.,8
Koufaki et al.,30 Roditis et al.,7 Smart et al.33
2.65 (1.27-4.03) 12 .0002
HIT protocol
HIT_L 4 Fu et al.,16 Huang et al.,19 Isaksen et al.,17 Roditis et al.7 2.45 (1.22-3.69) 7 < .00001
.87
HIT_S 6 Benda et al.,24 Chrysohoou et al.,6 Dimopoulos et al.,27
Freyssin et al.,8 Koufaki et al.,30 Smart et al.33
2.60 (1.37-3.82) 81 < .00001
Type of recovery
Active ( 20%) 7 Benda et al.,24 Freyssin et al.,8 Fu et al.,16 Huang et al.,19
Isaksen et al.,17 Koufaki et al.,30 Roditis et al.7
2.51 (1.68-3.33) 49 < .00001
.91
Passive (< 20%) 3 Chrysohoou et al.,6 Dimopoulos et al.,27 Smart et al.33 2.70 (–0.38-5.78) 60 .09
Active recovery intensity
 40% 5 Freyssin et al.,8 Fu et al.,16 Huang et al.,19 Isaksen et al.,17
Roditis et al.7
2.60 (1.68-3.51) 58 < .00001
.59
< 40% 2 Benda et al.,24 Koufaki et al.30 1.81 (–0.88-4.50) 0 .19
R (W/R)
 1 6 Chrysohoou et al.,6 Dimopoulos et al.,27 Fu et al.,16
Huang et al.,19 Isaksen et al.,17 Roditis et al.7
2.53 (1.45-3.62) 70 < .00001
.94
< 1 4 Benda et al.,24 Freyssin et al.,8 Koufaki et al.,30 Smart et al.33 2.45 (0.83-4.07) 0 < .00001
HF, heart failure; HIT, high-intensity interval training groups; HIT_L, protocol of HIT with long work interval; HIT_S, protocol of HIT with short work interval; I2, heterogeneity;
MD, mean difference; peak VO2, peak oxygen uptake; R (W/R), work-recovery ratio.
Certain studies were not included because they did not report the value used for subgroup analysis.
a Test for overall effect.
b Test for subgroup differences.
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protocols  12 weeks (P = .00001), although there were no
signiﬁcant differences between them (P = .96). This ﬁnding
suggests that, in both diseases, the exponential improvements
in peak VO2 were produced in the ﬁrst 12 weeks, when the HIT
protocol was more effective. These results were probably due to
the nonincremental workload included in the design of their
training session, which failed to adhere to the principle of
progression.40 This is explained by the fact that when a series of
effective stimuli is applied, the organism generates adaptations,Please cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp such as an increase in the muscle cross-sectional area, adaptations
of energy reserves, or increased synchronization of motor units.
The unchanging variability of these stimuli were therefore no
longer sufﬁcient to generate heterostasis. Thus, a coherent and
progressive increase of workloads is required.41
Likewise, there were no statistical differences between patients
with CAD or HF in the number of sessions ( 36 sessions6,8,11,13,16–
19,21,27,30,33,34 and < 36 sessions7,9,15,24,31,32 [18-156 sessions for
CAD patients and 18-72 sessions for HF patients]) and session
duration ( 28 minutes11,13,15,18,21,31,32 and < 28 minutes9 forterval Training Dosage for Heart Failure and Coronary Artery Disease
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Table 6
Subgroup Analyses Assessing Potential Moderating Factors for VO2 Peak Increase in Studies on CAD Disease Included in the Meta-analysis by Exercise
Characteristics
Peak VO2
Group HIT groups References MD (95%CI) I2 Pa P-differenceb
Number of sessions
 36 sessions 5 Cardozo et al.,11 Conraads et al.,18 Madssen et al.,13
Moholdt et al.,21 Warburton et al.34
3.57 (1.86-5.28) 0 < .00001
.6
< 36 sessions 4 Currie et al.,9 Kim et al.,15 Moholdt et al.,31 Rognmo et al.32 4.25 (2.35-6.14) 35 < .00001
Duration
> 12 ws 3 Cardozo et al.,11 Madssen et al.,13 Warburton et al.34 2.45 (0.62-4.29) 0 .009 .05
 12 ws 6 Conraads et al.,18 Currie et al.,9 Kim, et al.,15 Moholdt et al.,31
Moholdt et al.,21 Rognmo et al.32
4.70 (3.44-5.96) 0 < .00001
HIT frequency
 5 d/wk 1 Moholdt et al.31 3.30 (0.67-5.93) - .01 .82
3 or 4 d/wk 7 Cardozo et al.,11 Conraads et al.,18 Rognmo et al.,32
Warburton et al.,34 Kim et al.,15 Madssen et al.,13
Moholdt et al.21
3.91 (2.48-5.33) 16 < .00001
 2 d/wk 1 Currie et al.9 4.70 (1.26-8.14) — .007
Session duration
 28 min 7 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15 Madssen et al.,13
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.32
3.87 (2.71-5.02) 6 < .00001 .65
< 28 min 1 Currie et al.9 4.70 (1.26-8.14) — .007
Interval work
 4 min 7 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15 Madssen et al.,13
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.32
3.90 (2.59-5.22) 16 <.00001 .99
< 4 min 2 Currie et al.,9 Warburton et al.34 3.92 (1.28-6.55) 0 .004
Interval recovery
 3 min 8 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15 Madssen et al.,13
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.,32
Warburton et al.34
3.87 (2.71-5.02) 6 < .00001 .65
< 3 min 1 Currie et al.9 4.70 (1.26-8.14) — .007
HIT Protocol
HIT-L 7 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15 Madssen et al.,13
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.32
3.90 (2.59-5.22) 16 < .00001 .99
HIT-S 2 Currie et al.,9 Warburton et al.34 3.92 (1.28-6.55) 0 .004
Type of recovery
Active (20%) 8 Cardozo et al.,11 Conraads et al.,18 Rognmo et al.,32
Warburton et al.,34 Kim et al.,15 Moholdt et al.,31
Madssen et al.,13 Moholdt et al.21
3.87 (2.71-5.02) 6 < .00001 .65
Passive (<20%) 1 Currie et al.9 4.70 (1.26-8.14) — .007
Active recovery intensity
 65% 4 Cardozo et al.,11 Conraads et al.,18 Moholdt et al.,31
Moholdt et al.21
4.44 (3.24-5.63) < .00001 .27
< 65% 4 Kim et al.,15 Madssen et al.,13 Rognmo et al.,32
Warburton et al.34
2.86 (0.32-5.41)
R (W/R)
 1.33 7 Cardozo et al.,11 Conraads et al.,18 Kim et al.,15 Madssen et al.,13
Moholdt et al.,31 Moholdt et al.,21 Rognmo et al.32
3.87 (2.71-5.02) 6 < .00001 .65
< 1.33 2 Currie et al.,9 Warburton et al.34 4.70 (1.26-8.14) — .007
Certain studies were not included because they did not include the value used for subgroup analysis .CAD, coronary artery disease; HIT, high-intensity interval training
groups; HIT_L, protocol of HIT with long work interval; HIT_S, protocol of HIT with short work interval; I2, heterogeneity; MD, mean difference; peak VO2: peak oxygen
uptake; R (W/R), work-recovery ratio.
Certain studies were not included because they did not report the value used for subgroup analysis.
a Test for overall effect.
b Test for subgroup differences.
Table 7
Recommendations on HIT Protocol for HF and CAD Patients
Disease Frequency, d-wk Duration program, wks Session duration, min Intensity of recovery, peak VO2, % Ratio, work/recovery
HF  3 (2-5)  6 (6-24) 30-60 (28-60)  40% (40-70%)  1.33 (0.66-1.33)
CAD  2 (2-5)  6 (4-52) 30-60 (28-60)  40% (0-70%)  1 (0.5-1.33)
CAD, coronary artery disease; HF, heart failure; HIT, high-intensity interval training groups; peak VO2: peak oxygen uptake.
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 42 minutes7,16,17,19,24 for patients with HF [28-69 minutes]).
These results implied that HIT interventions should not necessarily
be composed of a high number of sessions or long session
durations to achieve an improvement in peak VO2 of patients with
CAD or HF. The minimum frequency of training needed to produce
signiﬁcant adaptations in peak VO2 was 6 weeks for both CAD
18
and HF6,16,19 patients. These results, together with those obtained
in this meta-analysis, suggest that the maximum beneﬁts in peak
VO2would be obtained between weeks 6 and 12. There is therefore
a need to accomplish an adequate training period to perceive the
effects produced in peak VO2 by long-term training protocols. For
this reason, it is important to optimize training through adherence
to the general principles of training.
In relation to the HIT protocol, this meta-analysis conﬁrms the
results that both HIT protocols with short work intervals and
protocol of HIT with long work intervals produce signiﬁcant
improvements in peak VO2 in patients with CAD
9,14,18 and in
patients with HF.6,8,16,19 Likewise, no signiﬁcant differences were
found between performing an HIT protocol with short work
interval or long work interval in either disease. These results may
be due to the improvements in peak VO2 of cardiovascular diseases
being more closely related to the intensity rather than to the
duration of the HIT protocol.5 This is because intensity is
the parameter that produces greater adaptations in the cardiovas-
cular system such as an increase in muscle cross-sectional area,
adaptations of energy reserves, or increased synchronization of
motor units.33,34 Therefore, the type of protocol is not as important
in the peak VO2 improvement as the training intensity and
frequency, for CAD and HF patients.
According to our meta-analysis, HIT improved peak VO2 in
patients with CAD or HF, although there were statistically
signiﬁcant differences between these diseases with a greater
improvement in patients with HF (P = .03). These results may be
due to the initial differences in peak VO2 (16.2-31.8 mL/kg/min
-1 in
CAD patients and 10.7-19.1 mL/kg/min-1 in HF patients), derived
from the fact that HF patients have impaired cardiac function and
the cardiac muscle was not able to pump enough blood to supply
the tissues.32 However, CAD patients saw a lesser impact on their
peak VO2, as they probably had better myocardial contractility,
particularly if they had undergone coronary intervention.42
As has been previously suggested, this should allow the
possibility of a higher increase in cardiac output because of a
higher systolic volume, resulting in a greater increase in left
ventricular ejection fraction in HF patients due to their having a
lower threshold of adaptation to the stimulus.7 Similarly, this
improvement could be caused by a larger relative increase in
exercise-induced vasodilation, hemoglobin, the skeletal muscle
oxidative capacity,5,8,18 or by the sum of all these factors.
Although it was not an objective of this study, there are studies
that compare the effects on peak VO2 between HIT and continuous
training. Although most studies have suggested that HIT is superior
to continuous exercise,15,16,21,23,43 some studies have reported that
HIT was not superior to continuous exercise programs in relation
to peak VO2 in the 2 diseases.
5,7,9,17–20,44,45
The present study makes an important contribution to the
understanding of the effectiveness of HIT training programs in
heart diseases. Thus, this study provides evidence for the potential
applicability of HIT training programs as part of the treatments
used for CAD and HF.
Practical Application
The results of this study indicate that HIT positively affects peak
VO2 in people with HF or CAD, providing greater advantages in HFPlease cite this article in press as: Ballesta Garcı´a I, et al. High-intensity In
Cardiac Rehabilitation. A Systematic Review and Meta-analysis. Rev Esp patients. These ﬁndings could be used by physicians, physical
conditioning trainers and heart rehabilitation teams to develop
speciﬁc training programs in order to optimize the functioning of
the patient’s heart. However, other variables have to be taken into
account, such as age, training frequency, the duration of program,
and the type of recovery. The HIT program should therefore be
adapted to the individual characteristics of each patient. The
recommended dosage for each disease is shown in Table 7.
Limitations
The main limitations of this study are as follow: a) the
randomized controlled trials did not use the same methods to
control the intensity of the training sessions; b) the protocols and
the age of the participants were widely heterogeneous; c) most of
the included studies had a sample with few patients; and d) in HIT
protocols, one aspect is the design and another the intensity that
patients are capable of achieving. Therefore, the possibility that a
patient has not been able to accomplish the planned intensities
should be considered.
CONCLUSIONS
The results of this study show that HIT is an effective method for
the treatment of HF and CAD by improving peak VO2, with the
increase being signiﬁcantly higher in HF patients. To optimize
these beneﬁts, recovery intervals should be active at intensities
between 40% to 60% of peak VO2 for HF patients, and the frequency
should be  2 d/wk for CAD patients and  3 d/wk for HF patients.
This study opens a new line of research that could be used to
optimize high-quality exercise training protocols in an effort
to develop the most effective and efﬁcient method for the
treatment of heart disease and other diseases.
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WHAT IS KNOWN ABOUT THE TOPIC?
– The HIT produces positive cardiovascular adaptations in
HF and CAD patients.
– The HIT improves peak VO2 in HF and CAD patients.
WHAT DOES THIS STUDY ADD?
– The HIT is more effective in improving peak VO2 in HF
patients than in CAD patients.
– To obtain improvements in peak VO2 through HIT,
 3 sessions per week for at least 6 weeks are needed for
HF patients, and  2 sessions per week for at least
6 weeks for CAD patients.
– Active recovery at intensities between 40% to 60% of peak
VO2 should be used to improve peak VO2 in HF patients.terval Training Dosage for Heart Failure and Coronary Artery Disease
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